About this scholarly article

LATE-BREAKING ABSTRACT: PT003, a novel co-suspension MDI glycopyrronium/formoterol fixed-dose combination is superior to monocomponents in patients with COPD by Rabe, Klaus (author);Martinez, Fernando (author);Rodriguez-Roisin, Roberto (author);Fabbri, Leonardo M. (author);Ferguson, Gary T. (author);Jones, Paul (author);Rennard, Stephen (author);Golden, Michael (author);Darken, Patrick (author);Orevillo, Chad (author);Fischer, Tracy (author);Reisner, Colin (author) is a scholarly article available to read on EtoBox.

Author

Rabe, Klaus (author);Martinez, Fernando (author);Rodriguez-Roisin, Roberto (author);Fabbri, Leonardo M. (author);Ferguson, Gary T. (author);Jones, Paul (author);Rennard, Stephen (author);Golden, Michael (author);Darken, Patrick (author);Orevillo, Chad (author);Fischer, Tracy (author);Reisner, Colin (author)

Publisher

European Respiratory Society (ERS)

Published

2015